Review
Published on 29 Apr 2025
MYCN as an oncogene in pediatric brain tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1584978
- 494 views
Type at least 3 characters
30,941 articles
Case Report
Published on 29 Apr 2025
A case report of rare pancreatic lymphoma: wide range of diffuse large B-cell lymphoma located in the body and tail of pancreas
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1563729
- 264 views
Original Research
Published on 29 Apr 2025
Comparative efficacy of surgery and radiotherapy in achieving local control in Kimura disease: a retrospective analysis of treatment outcomes
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1587648
- 256 views
Original Research
Published on 29 Apr 2025
LSM2 drives glioma progression through alternative splicing dysregulation: a multi-omics approach to identify a potential therapeutic target
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1521608
- 254 views
Case Report
Published on 29 Apr 2025
Renal cell carcinoma of the native kidney in renal transplant recipients: case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1536411
- 264 views
Original Research
Published on 29 Apr 2025
HALP score as a prognostic marker for overall survival in advanced pancreatic cancer
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1542463
- 251 views
Case Report
Published on 29 Apr 2025
Copy number gain of MET gene with low level in a metastatic lung adenocarcinoma patient represents response to salvage treatment with savolitinib and osimertinib: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1507677
- 205 views
Review
Published on 29 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
- 284 views
Case Report
Published on 29 Apr 2025
Robotic-assisted gastrointestinal stromal tumor (GIST) resection with endoscopic transoral specimen retrieval (Gastrointestinal Cancer-NOSES Type IX): a case report and literature review
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1580558
- 230 views
Original Research
Published on 29 Apr 2025
Association of aggregate index of systemic inflammation with increased all-cause and cardiovascular mortality in female cancer patients
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2025.1552341
- 327 views
Original Research
Accepted on 28 Apr 2025
Clinicopathological features and risk factors for local recurrence of breast phyllodes tumors: a dual-center, 12-year, retrospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1538523
Case Report
Accepted on 28 Apr 2025
Locally Invasive Thyroid Metastases from Renal Cell Carcinoma: Surgery after Neoadjvant Therapy
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1543060
Original Research
Accepted on 28 Apr 2025
External validation of the Oncotype DX breast cancer recurrence score nomogram and development and validation of a novel machine learning-based model to predict postoperative overall survival and guide adjuvant chemotherapy in ER positive, Her-2 negative breast cancer patients: a retrospective cohort study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1586262
Original Research
Accepted on 28 Apr 2025
Comparative Analysis of Multi-zone Peritumoral Radiomics in Breast Cancer for Predicting NAC Response Using ABVS-based Deep Learning Models
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1586715
Original Research
Accepted on 28 Apr 2025
Impact of Hashimoto's Thyroiditis on Ultrasound Diagnosis of Papillary Thyroid Carcinoma: A Retrospective Study
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1551114
Original Research
Accepted on 28 Apr 2025
AMPs inhibit the proliferation, migration, and invasion of lung cancer via the CHRM3/PI3K/AKT and CHRM3/MAPK pathways
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1582040